JPWO2018191748A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2018191748A5 JPWO2018191748A5 JP2019555484A JP2019555484A JPWO2018191748A5 JP WO2018191748 A5 JPWO2018191748 A5 JP WO2018191748A5 JP 2019555484 A JP2019555484 A JP 2019555484A JP 2019555484 A JP2019555484 A JP 2019555484A JP WO2018191748 A5 JPWO2018191748 A5 JP WO2018191748A5
- Authority
- JP
- Japan
- Prior art keywords
- car
- seq
- cell
- antigen
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024014208A JP2024062986A (ja) | 2017-04-14 | 2024-02-01 | 腫瘍微小環境を標的にするキメラ抗原受容体ｔ細胞 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762485670P | 2017-04-14 | 2017-04-14 | |
| US62/485,670 | 2017-04-14 | ||
| US201862629593P | 2018-02-12 | 2018-02-12 | |
| US62/629,593 | 2018-02-12 | ||
| PCT/US2018/027783 WO2018191748A1 (en) | 2017-04-14 | 2018-04-16 | Chimeric antigen receptor t cells targeting the tumor microenvironment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014208A Division JP2024062986A (ja) | 2017-04-14 | 2024-02-01 | 腫瘍微小環境を標的にするキメラ抗原受容体ｔ細胞 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020516276A JP2020516276A (ja) | 2020-06-11 |
| JP2020516276A5 JP2020516276A5 (zh) | 2021-05-27 |
| JPWO2018191748A5 true JPWO2018191748A5 (zh) | 2023-10-26 |
| JP7505885B2 JP7505885B2 (ja) | 2024-06-25 |
Family
ID=63793633
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019555484A Active JP7505885B2 (ja) | 2017-04-14 | 2018-04-16 | 腫瘍微小環境を標的にするキメラ抗原受容体ｔ細胞 |
| JP2024014208A Pending JP2024062986A (ja) | 2017-04-14 | 2024-02-01 | 腫瘍微小環境を標的にするキメラ抗原受容体ｔ細胞 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014208A Pending JP2024062986A (ja) | 2017-04-14 | 2024-02-01 | 腫瘍微小環境を標的にするキメラ抗原受容体ｔ細胞 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20200113940A1 (zh) |
| EP (1) | EP3609914A4 (zh) |
| JP (2) | JP7505885B2 (zh) |
| CN (1) | CN110520524A (zh) |
| AU (2) | AU2018251206A1 (zh) |
| CA (1) | CA3059444A1 (zh) |
| WO (1) | WO2018191748A1 (zh) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210038646A1 (en) * | 2018-02-12 | 2021-02-11 | The General Hospital Corporation | Chimeric antigen receptors targeting the tumor microenvironment |
| WO2020020359A1 (en) * | 2018-07-26 | 2020-01-30 | Nanjing Legend Biotech Co., Ltd. | Nef-containing t cells and methods of producing thereof |
| WO2020092455A2 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Car t cell transcriptional atlas |
| US20220323495A1 (en) * | 2019-03-27 | 2022-10-13 | National Research Council Of Canada | Antigen-binding agents that specifically bind epidermal growth factor receptor variant iii |
| CN114007642A (zh) | 2019-04-30 | 2022-02-01 | 森迪生物科学公司 | 嵌合受体及其使用方法 |
| WO2020232247A1 (en) | 2019-05-14 | 2020-11-19 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| EP3747904A1 (en) * | 2019-06-03 | 2020-12-09 | Universität Regensburg | Cd25-specific chimeric antigen receptors and their uses |
| MX2022001711A (es) * | 2019-08-09 | 2022-05-10 | A2 Biotherapeutics Inc | Receptores en la superficie celular que responden a la perdida de heterocigosidad. |
| US20220411530A1 (en) * | 2019-11-22 | 2022-12-29 | Nantong Yichen Biopharma. Co. Ltd. | PSMA Antibody and Use Thereof |
| US12006366B2 (en) | 2020-06-11 | 2024-06-11 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| CA3188867A1 (en) | 2020-08-20 | 2022-02-24 | Xueyin Wang | Compositions and methods for treating ceacam positive cancers |
| AU2021329371A1 (en) | 2020-08-20 | 2023-04-20 | A2 Biotherapeutics, Inc. | Compositions and methods for treating mesothelin positive cancers |
| JP2023550148A (ja) * | 2020-11-20 | 2023-11-30 | シンシア・イノベーション・インコーポレイテッド | がん免疫治療に用いられる武装二重ｃａｒ－ｔ組成物及び方法 |
| CN115491358A (zh) * | 2021-06-17 | 2022-12-20 | 复星凯特生物科技有限公司 | 一种靶向b7-h3和folr1双打靶点car t的制备及应用 |
| CN117940138A (zh) * | 2021-07-01 | 2024-04-26 | 宁波茂行生物医药科技有限公司 | 靶向egfr的通用型car-t细胞及其制备方法 |
| TWI823402B (zh) * | 2021-07-21 | 2023-11-21 | 長聖國際生技股份有限公司 | 多特異性單域抗體嵌合抗原受體及t細胞銜接體、核酸、其表達細胞、其用途以及治療癌症之醫藥組合物 |
| WO2023077068A1 (en) * | 2021-10-28 | 2023-05-04 | Skunkworx Bio, Inc. | Novel binding agents related to glycoprotein-a |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050136035A1 (en) * | 2003-06-03 | 2005-06-23 | Derek Ko | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| PT3459560T (pt) * | 2011-04-08 | 2021-05-24 | Us Health | Recetores de antigénio quimérico variante iii de recetor de fator de crescimento antiepidérmico e utilização dos mesmos para o tratamento de cancro |
| EP3626741A1 (en) * | 2013-02-20 | 2020-03-25 | The Trustees Of The University Of Pennsylvania | Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor |
| JP6420776B2 (ja) * | 2013-03-05 | 2018-11-07 | ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ | 免疫療法のためのエンゲージャー細胞 |
| EP2970426B1 (en) * | 2013-03-15 | 2019-08-28 | Michael C. Milone | Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy |
| EP3027650B1 (en) * | 2013-08-01 | 2021-01-13 | Université catholique de Louvain | Antibody binding a complex of human glycoprotein a repetitions predominant (garp) and latent tgf-beta-1 |
| CA2956307A1 (en) * | 2014-07-29 | 2016-02-04 | Pfizer Inc. | Egfrviii specific chimeric antigen receptors for cancer immunotherapy |
| HRP20240357T1 (hr) * | 2014-12-24 | 2024-06-07 | Autolus Limited | Stanica |
| KR101997241B1 (ko) * | 2015-05-21 | 2019-07-09 | 하푼 테라퓨틱스, 인크. | 삼중특이성 결합 단백질 및 사용 방법 |
| WO2017222593A1 (en) * | 2016-06-24 | 2017-12-28 | Icell Gene Therapeutics Llc | Chimeric antigen receptors (cars), compositions and methods thereof |
| US11890301B2 (en) * | 2015-08-28 | 2024-02-06 | The Trustees Of The University Of Pennsylvania | Methods and compositions for cells expressing a chimeric intracellular signaling molecule |
| US20180258149A1 (en) * | 2015-09-17 | 2018-09-13 | Novartis Ag | Car t cell therapies with enhanced efficacy |
| US9567399B1 (en) * | 2016-06-20 | 2017-02-14 | Kymab Limited | Antibodies and immunocytokines |
-
2018
- 2018-04-16 US US16/603,675 patent/US20200113940A1/en active Pending
- 2018-04-16 CN CN201880025361.8A patent/CN110520524A/zh active Pending
- 2018-04-16 EP EP18784599.5A patent/EP3609914A4/en active Pending
- 2018-04-16 CA CA3059444A patent/CA3059444A1/en active Pending
- 2018-04-16 AU AU2018251206A patent/AU2018251206A1/en not_active Abandoned
- 2018-04-16 JP JP2019555484A patent/JP7505885B2/ja active Active
- 2018-04-16 WO PCT/US2018/027783 patent/WO2018191748A1/en unknown
-
2023
- 2023-09-28 US US18/477,532 patent/US20240075070A1/en active Pending
- 2023-12-07 AU AU2023278069A patent/AU2023278069A1/en active Pending
-
2024
- 2024-02-01 JP JP2024014208A patent/JP2024062986A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516276A5 (zh) | ||
| EP4083073A1 (en) | Novel chimeric antigen receptor and use thereof | |
| US20230399398A1 (en) | Cd7-targeting humanized antibody and use thereof | |
| JPWO2018191748A5 (zh) | ||
| JP2019088330A (ja) | 二重特異性キメラ抗原受容体およびその治療的使用 | |
| JP2018046811A (ja) | 異常細胞を標的とする多重特異性結合分子 | |
| EP4257610A1 (en) | Ror1-targeting antibody and use thereof | |
| US20220185882A1 (en) | Artificial immunosurveillance chimeric antigen receptor (ai-car) and cells expressing the same | |
| WO2023046047A1 (zh) | 一种异源二聚体蛋白质及其应用 | |
| US20230348556A1 (en) | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same | |
| US9200078B2 (en) | Antibodies against prostate-specific stem cell antigen and use thereof | |
| CN115943165A (zh) | Fc-CD80融合蛋白和其缀合物以及它们的用途 | |
| CA3129200A1 (en) | Il-4r as a biomarker in cancer | |
| JPWO2019157533A5 (zh) | ||
| US20230365686A1 (en) | Humanized antibody specific for cd22 and chimeric antigen receptor using the same | |
| JP2023552865A (ja) | 条件付き二重特異性結合タンパク質 | |
| US20240018236A1 (en) | Cd19-targeting humanized antibody and use thereof | |
| WO2024008039A1 (zh) | 一种异源二聚体融合蛋白及其应用 | |
| US20230183351A1 (en) | A targeting module comprising pd-l1 and/or pd-l2 for use in a method for stimulating a chimeric antigen receptor mediated immune response in a mammal | |
| WO2024093882A1 (zh) | 一种cd24结合蛋白及其用途 | |
| EP4159760A1 (en) | Antibody specific to cd22, and use thereof | |
| US20220195006A1 (en) | Peptide markers to track genetically engineered cells | |
| WO2024121414A1 (en) | Chimeric antigen receptor | |
| EP4294830A2 (en) | Antibody-derived t cell activating technologies | |
| CA3234046A1 (en) | Anti-bcma single domain antibodies and therapeutic constructs |